WeVote
Log In

Bill

Bill

SB 410

Pharmacy benefits managers; various requirements, report.

2026 Regular Session Introduced by Mark Peake

Virginia bill establishing pharmacy benefit manager oversight requirements and reporting obligations to increase regulatory transparency and market accountability.

Incorporated by Commerce and Labor (SB669-Rouse) (15-Y 0-N)
0
WeVote Research Nonpartisan
Bill Summary · SB 410

Legislative bill overview

SB 410 establishes various regulatory requirements and reporting obligations for pharmacy benefit managers (PBMs) operating in Virginia. The bill was incorporated into SB 669, suggesting its provisions were merged into broader legislation addressing PBM practices and oversight.

Why is this important

PBMs act as intermediaries between insurers, pharmacies, and patients, controlling drug formularies and pricing. Regulatory requirements can affect prescription drug accessibility, medication costs for consumers, and pharmacy operational viability—making this relevant to healthcare affordability and market competition.

Potential points of contention

  • Industry compliance burden: New reporting requirements and regulations may increase operational costs for PBMs, potentially passed to insurers and ultimately patients through higher premiums
  • Scope and enforceability: The specific requirements remain unclear from available information, but transparency mandates could conflict with PBM proprietary business practices and competitive concerns
  • Market impact uncertainty: Regulations intended to increase competition and lower drug costs may have unintended consequences on PBM consolidation, formulary design, or pharmacy network participation

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.